Skip to content

CORE LABORATORIES INC (CLB)

Energy · oil and gas equipment and services · NYSE

Core Laboratories provides specialized laboratory analysis and technology-driven services to help oil and gas companies maximize production and recovery from their reservoirs.

What CORE LABORATORIES INC does

Core Laboratories provides reservoir description, reservoir management, and reservoir enhancement services and products to the oil and gas industry. The company assists clients in optimizing hydrocarbon recovery from their producing fields through advanced technologies and laboratory analysis. Its operations span the global upstream energy market, focusing on both conventional and unconventional oil and gas reservoirs.

Themes: reservoir optimization, enhanced oil recovery (EOR), upstream energy services, hydrocarbon production efficiency

Fundamentals

  • Price$12.52 as of 2026-08-21 close
  • Market cap$574M as of 2026-08-21
  • 1-year return+19.7% 2025-08-21 close $10.46 → 2026-08-21 close $12.52
  • P/E23.34 as of 2026-08-24
  • Net margin+4.7% as of 2026-08-24
  • Gross margin+19.5% as of 2026-08-24
  • ROE+9.0% as of 2026-08-24
  • Debt / equity0.42 as of 2026-08-24
  • Revenue growth (YoY)+0.3% as of 2026-08-24
  • Revenue CAGR (3y)+2.4% SEC XBRL
  • Beta1.13 as of 2026-08-24
  • Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)

Dividend: yield +0.2%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.

Ask why CLB looks like this →

How CLB compares in its sector

  • price-to-earnings ratiomiddle range 118 covered Energy peers, as of 2026-08-24
  • net profit marginmiddle range 149 covered Energy peers, as of 2026-08-24
  • operating marginmiddle range 149 covered Energy peers, as of 2026-08-24
  • gross marginbottom 25% 142 covered Energy peers, as of 2026-08-24
  • return on equitymiddle range 152 covered Energy peers, as of 2026-08-24
  • 3-year revenue CAGRmiddle range 138 covered Energy peers
  • indicated dividend yieldbottom 10% 98 covered Energy peers, as of 2026-08-24
  • free cash flow (absolute dollars, latest fiscal year)middle range 95 covered Energy peers, as of FY2025

Position among covered Energy companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.

Ask how CLB stacks up against peers →

Dividend coverage (FY2025)

Covered by reported results. In FY2025, CLB's dividend was covered by reported results (earnings payout 6%, free-cash-flow payout 7%). This describes past coverage, not a forecast.

  • Earnings payout6% dividends / net income
  • Free-cash-flow payout7% dividends / (operating cash flow − capex)

Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.

Ask whether CLB's dividend is covered →

How CORE LABORATORIES INC looks technically

CORE LABORATORIES INC (CLB) is trading 17.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 55 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 22 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 3 trading days ago. It is 38.3% below its highest point of the past year.

Trend

7
Distance from the 200-dayit is trading 17.7% below its 200-day average, the long-term trend line — a long-term downtrend-17.7%
50-day moving averageits average price over the last 50 trading days — a short-term trend line — is $11.59$11.59
200-day moving averageits average price over the last 200 trading days — the long-term trend line — is $15.21$15.21
Swing structureits recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swingsmixed — one of the two is not confirming
Last swing turnits last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on7 sessions
Since the 50/200 crossits 50-day average crossed below its 200-day average about 55 trading days ago — a "death cross", a bearish long-term signal55 sessions
Trend strength (14-day ADX)a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 22 (a reading of 25+ marks a strong trend)21.9

Momentum

3
14-day RSImomentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 59, neither overbought (above 70) nor oversold (below 30)59.3
Position in its 14-day rangeit is trading near the top of its 14-day range ($10.32 to $12.85) — its "stochastic" reading is 87 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions.87.0
Since the MACD crossed zeroMACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish)14 sessions

Range

12
52-week highits highest closing price over the past year (about 252 trading days) was $20.31$20.31
From the 52-week highit is 38.3% below its 52-week high (its highest price of the past year)-38.4%
Above the 52-week lowit is 27.8% above its 52-week low (its lowest price of the past year)+27.8%
Below the 52-week highit is 38.3% below its highest point of the past year38.4%
Since a 20-day breakoutit made a new 20-day high about 3 trading days ago3 sessions
Since a 55-day breakoutit made a new 55-day low about 18 trading days ago18 sessions
All-time highits highest closing price on record is $221.00 (set on 2014-04-17)$221.00
Given back of the 52-week moveover the past year its closes ranged ($9.87 to $19.67), and it has recovered roughly a quarter of its fall from last year’s high — 27% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $15.93 to $16.24. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast.27.0%
From the all-time highit is 94.3% below its all-time high-94.3%
Nearest price levelit is trading 2.0% above a support level at $12.27 — a price it turned at twice since 2026-07-01, most recently on 2026-07-23. Since 2024-08-21 it has 6 such levels below the current price and 16 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go.-2.0%
All-time lowits lowest closing price on record is $6.68 (set on 2020-03-18)$6.68
Above the all-time lowit is 87.4% above its all-time low+87.4%

Volatility

5
Band width vs its own 6 monthsday-to-day price swings are unusually wide versus its own recent history (wider than about 81% of the past ~6 months)81st percentile
Typical daily rangein a typical session it travels about $0.5177 between its high and its low — about 4.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was$0.5177
Bollinger bands (20-day, ±2σ)most of its recent trading has stayed between about $9.88 and $13.40 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles$9.88 – $11.64 – $13.40
Typical daily range (% of price)its price moves about 4.1% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price4.1%
Stretch from the 200-day averageit is trading 5.2 daily ranges below its 200-day average price (17.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale5.2 daily ranges below its 200-day average

Volume

1
Volume vs its 30-day averagetrading volume is about normal versus its 30-day average0.55×

Analyst

2
Change in the average price targetanalysts have cut their average price target by 2.2% since the prior reading-2.1%
Change in the consensus ratingthe analyst consensus rating has improved toward "buy" since the prior reading0.67 toward buy

Candlestick patterns

1
Since a doji5 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level5 sessions ago

Price gaps

2
Gap at the openit opened on 2026-08-21 0.7% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close+0.7%
Gap filleda 2.1% gap down opened on 2026-06-15 has been "filled" 47 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it47 sessions ago

Price streaks

1
Closing streakit closed higher in its latest session, after a session that did not close higher — a single up day rather than a run1 session up

Relative strength

4
vs market, 1 monthover the past 1 month this stock beat the market by 7.4 percentage points (the stock gained 9.7% while the market gained 2.3%)+7.4%
vs market, 3 monthsover the past 3 months this stock lagged the market by 16.8 percentage points (the stock lost 13.7% while the market gained 3.1%)-16.8%
vs market, 6 monthsover the past 6 months this stock lagged the market by 43.1 percentage points (the stock lost 32.0% while the market gained 11.1%)-43.1%
vs market, 12 monthsover the past 12 months this stock lagged the market by 0.8 percentage points (the stock gained 19.7% while the market gained 20.5%)-0.8%

Signal agreement

2
Bullish technical signals2 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast2 of 9
Bearish technical signals4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast4 of 9

Trend (Ichimoku cloud)

1
Vs the Ichimoku cloudtrading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is thick, spanning 17.8% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross.0.0%

Volume-weighted price

2
Vs this year’s average price paidthe price is 9% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $13.80 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP.-9.3%
Vs the average paid since it last reportedthe price is 9% above the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $11.44 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP.+9.4%

Price levels it has turned at before

CLB last closed at $12.52 on 2026-08-21. Since 2024-08-21 it has turned at 6 prices below its last close and 16 above; the 3 nearest below and the 3 nearest above are listed, nearest first.

LevelSideDistanceEvidence
$12.27Support2.0% below the last closeturned there twice · 2026-07-01 to 2026-07-23
$12.95Resistance3.4% above the last closeturned there five times · 2025-03-05 to 2026-08-14
$13.21Resistance5.5% above the last closeturned there three times · 2025-04-24 to 2025-09-09
$11.77Support6.0% below the last closeturned there twice · 2025-09-22 to 2026-07-13
$13.76Resistance9.9% above the last closeturned there twice · 2025-07-24 to 2025-11-21
$11.10Support11.4% below the last closeturned there three times · 2025-04-30 to 2025-07-17

A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.

Wave structure

No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.

Read from daily closes as of 2026-08-21.

An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.

Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.

Ask about CLB's technicals →

Analyst consensus

  • Consensus ratingBuy (2.33 mean, 1=Strong Buy…5=Strong Sell) — 3 analysts
  • Mean price target$15.17 range $11.00 – $21.00; median $13.50

Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.

Analyst EPS estimate for CLB

  • Consensus EPS estimate$0.1533 next reporting period, as of 2026-08-19

Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.

The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.

Ask how CLB's estimates have moved →

Key risks (from latest filing)

["volatility in global oil and gas prices and capital expenditures","geopolitical instability in regions where the company operates","reliance on continued customer demand for advanced reservoir optimization technologies"]

See CLB's biggest risks from its latest 10-Q →

What changed in the latest 10-Q

AI-assisted comparison of CLB's 10-Q filed 2026-05-01 against the prior one filed 2025-10-23.

Management's Discussion & Analysis (MD&A)

  • Reworded:
    • Reference date changed from 'September 30, 2025' to 'March 31, 2026' in opening paragraph (newer filing 2026-05-01)
    • Reference to 'our 2024 Annual Report on Form 10-K for the year ended December 31, 2024' changed to 'our 2025 Annual Report on Form 10-K for the year ended December 31, 2025' (newer filing 2026-05-01)
    • Page number changed from '21' to '19' at end of section (newer filing 2026-05-01)
  • Notes:
    • The two filings appear substantially identical in content; changes are limited to dates and page numbers reflecting the different reporting periods
    • Both sections are truncated at the end with incomplete text ('For a more detailed discussion of some of the foregoing risks and uncertainties, see Part II, "')

Risk Factors

The two filings could not be meaningfully compared for this section.

AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.

Ask what changed in CLB's latest 10-Q →

Insider activity (SEC Form 4)

1 open-market purchase and 0 open-market sales by insiders in the last 90 days.

  • Last 30 days1 buy ($53900) · 0 sells — 1 buying insider
  • Last 90 days1 buy ($53900) · 0 sells — 1 buying insider
  • Last 180 days1 buy ($53900) · 0 sells — 1 buying insider

Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)

Most recent open-market transaction: 2026-07-31. As of 2026-08-24.

View full insider trading history → View SEC Form 3/4/5 filings

Ask about CLB's insider activity →

Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.

Institutional ownership (13F)

5 institutional 13F filers reported holding CLB as of 2026-03-31 (quarter-end position, filed within 45 days).

  • Distinct 13F filers 5
  • Reported shares held 9,498,030
  • Reported value $159,471,920

reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".

Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.

Ask about CLB's institutional holders →

Short interest (FINRA)

CLB had 4,194,215 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).

CLB had 9.14% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.02 days to cover at the same settlement.

  • Reported short interest (shares) 4,194,215
  • Short interest (% of shares outstanding) 9.14%
  • Prior settlement (shares) 4,023,689
  • Reported change 4.24%
  • Days to cover (reported) 5.02

Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.

Ask about CLB's short interest →

Competitors & peers

AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.

Not quite? Describe exactly what you want →

Compare CLB vs…

Frequently asked questions

What does CORE LABORATORIES INC (CLB) do?

Core Laboratories provides reservoir description, reservoir management, and reservoir enhancement services and products to the oil and gas industry. The company assists clients in optimizing hydrocarbon recovery from their producing fields through advanced technologies and laboratory analysis. Its operations span the global upstream energy market, focusing on both conventional and unconventional oil and gas reservoirs.

What sector is CORE LABORATORIES INC (CLB) in?

CORE LABORATORIES INC (CLB) is classified in the Energy sector. Its industry is oil and gas equipment and services. It trades on NYSE.

Does CLB pay a dividend?

Yes — CORE LABORATORIES INC (CLB) pays a dividend, with an indicated yield of about 0.16% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.

Who are CORE LABORATORIES INC's (CLB) competitors?

Notable peers of CORE LABORATORIES INC (CLB) include Schlumberger, Halliburton, Baker Hughes, Weatherford International and TechnipFMC. This peer set is informational only — not financial advice.

Is CORE LABORATORIES INC (CLB) overbought or oversold right now?

CORE LABORATORIES INC (CLB) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 59, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.

Where does stocks-llm's data on CLB come from?

Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.

Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-08-21.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.

Research stocks in your own words.

Informational only — NOT financial advice.

ScreenersBlogPrivacyiOS app